市場調査レポート
商品コード
1482328

オピオイドの市場規模・予測、世界・地域シェア、動向、成長機会分析レポート:製品別、用途別、投与経路別、流通チャネル別、地域別

Opioids Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, Route Of Administration, Distribution Channel, and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 209 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=159.16円
オピオイドの市場規模・予測、世界・地域シェア、動向、成長機会分析レポート:製品別、用途別、投与経路別、流通チャネル別、地域別
出版日: 2024年05月03日
発行: The Insight Partners
ページ情報: 英文 209 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

オピオイド市場は、2023年の129億3,000万米ドルから2031年には150億3,000万米ドルに成長すると予想され、2023年から2031年までのCAGRは1.9%を記録すると予測されています。

オピオイドは、主に痛みを和らげるために使用される幅広い医薬品群です。これらの医薬品は非常に効果的であるが、中毒を引き起こす可能性もあります。オピオイドは脳の受容体に作用することで、鎮痛を含む様々な効果をもたらします。オピオイドには、ヘロイン、モルヒネ、コデイン、フェンタニル、メタドン、トラマドール、その他類似物質が含まれます。オピオイドの市場規模が拡大している背景には、世界中で慢性疼痛が急増していることがあります。また、世界中で老年人口が増加していることも、オピオイド市場の成長に拍車をかけています。オピオイドの過剰摂取や障害を予防・治療する薬物の開拓に重点を置く政府の取り組みは、予測期間中に新たなオピオイド市場動向をもたらす可能性が高いです。

市場プレイヤーの戦略的取り組みがオピオイド市場成長の機会を生む

オピオイド市場のプレーヤーは、効果的な製品の開発を確実にするため、研究開発活動に投資しています。2023年5月、Indivior PLCは、12歳以上の成人および小児患者において、合成または天然オピオイドによって誘発されたオピオイド過剰摂取の疑いまたは既知のオピオイド過剰摂取を治療するための緊急用として、中枢神経系および/または呼吸抑制を特徴とするOPVEE(ナルメフェン)点鼻スプレーの米国食品医薬品局(FDA)の承認を取得しました。さらに、サンドは2021年12月、米国でジェネリック医薬品「Narcan(ナロキソン塩酸塩)点鼻スプレー4mg」を発売すると発表しました。同製品はオピオイドの過剰摂取を抑制するもので、米国では小売薬局や病院などの医療機関で直ちに入手することができます。最後に、2023年8月、Emergent BioSolutions社は市販のNARCAN点鼻スプレーを発売し、誰もがオピオイド過剰摂取の緊急事態から命を救う手助けができるようになった。そのため、戦略的イニシアティブは今後数年間、オピオイド市場に成長機会を提供する可能性が高いです。

地域別に見ると、オピオイド市場は北米(米国、カナダ、メキシコ)、欧州(英国、ドイツ、フランス、イタリア、スペイン、ロシア、その他欧州地域)、アジア太平洋(中国、日本、インド、韓国、オーストラリア、東南アジア、その他アジア太平洋地域)、中東・アフリカ(アラブ首長国連邦、サウジアラビア、南アフリカ、オーストラリア、東南アジア、その他中東・アフリカ地域)、南米・中米(ブラジル、アルゼンチン、その他中東・アフリカ地域)に区分されます。北米は、2023年の世界オピオイド市場で最大のシェアを占めました。しかし、アジア太平洋地域は2023-2031年に最も高いCAGRを記録すると予測されています。米国は2022年に北米のオピオイド市場で最大のシェアを占めました。米国の市場プレーヤーは、オピオイド市場開拓のために有機的・無機的戦略を採用しています。例えば、2024年にHikma Pharmaceuticals PLCは、25mcg/0.5mLと50mcg/mLの用量のFentanyl Citrate Injection, USPを発売しました。Hikma社は、FDAが承認した最初の25mcg/0.5mL製剤を米国市場に投入しました。同社はこの発売によりポートフォリオを拡大し、病院が利用できる医薬品の選択肢を広げることが期待されます。さらに2023年、ルサン・ファーマはインドのマディヤ・プラデシュ州に最新鋭の原薬施設を開設しました。この施設は厳格な国際規制ガイドラインに適合するよう設計されており、最高レベルのコンプライアンスを保証します。年間400トンの原薬生産能力を持っています。この施設拡張により、インドおよび世界の依存症治療および疼痛管理製品に対する需要の高まりに対応するため、重要な原薬の安定供給が確保されます。さらに2023年、ニューラクスファーム社は、サノフィ社から中枢神経系疾患、疼痛、血管疾患の2つの確立された製品ポートフォリオの買収完了を発表しました。ニューラクスファーマが買収した確立された製品には、中枢神経系疾患に対応する15製品、疼痛と血管疾患の2製品が含まれ、2022年にはコレギウム・ファーマシューティカル社がバイオデリバリー・サイエンシズ・インターナショナル社の買収完了を発表しました。BDSIは、重篤で衰弱させる疾患に対処する疼痛・神経系製品のポートフォリオを有しています。BDSI社の商業的成長の原動力であるBELBUCAは、スケジュールIIIのオピオイド製品であり、コレギウム社の疼痛製品ポートフォリオとの補完性が高いです。このように、上記の要因が市場の成長を支えています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 オピオイド市場情勢

  • PEST分析

第5章 オピオイド市場- 主要市場力学

  • オピオイド市場- 主な市場力学
  • 市場促進要因
    • 慢性疼痛の急増
    • 老年人口の増加
  • 市場抑制要因
    • 薬物乱用の増加
  • 市場機会
    • 市場プレイヤーの戦略的取り組み
  • 今後の動向
    • オピオイドの過剰摂取と障害を予防・治療する薬の開発に焦点を当てた政府の取り組み
  • 促進要因と抑制要因の影響

第6章 オピオイド市場:世界市場分析

  • オピオイド市場の収益、2022年~2030年
  • オピオイド市場予測分析

第7章 オピオイド市場分析:製品別

  • 即時放出短時間作用型オピオイド
  • 徐放性長時間作用型オピオイド

第8章 オピオイド市場分析:用途別

  • 疼痛管理
  • 麻酔薬
  • 下痢抑制
  • 咳止め
  • 脱中毒
  • その他

第9章 オピオイド市場分析:投与経路別

  • 経口
  • 注射剤
  • 経皮パッチ

第10章 オピオイド市場分析:流通チャネル別

  • 病院薬局
  • 小売薬局

第11章 オピオイド市場分析:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • APACのその他諸国
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • その他中東とアフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米

第12章 業界情勢

  • オピオイド市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略
    • 成長戦略

第13章 企業プロファイル

  • Purdue Pharma LP
  • Endo International plc
  • Mallinckrodt Plc
  • Collegium Pharmaceutical Inc
  • Neuraxpharm Pharmaceuticals SL
  • Hikma Pharmaceuticals Plc
  • Mayne Pharma Group Ltd
  • Rusan Pharma Ltd
  • Trevena Inc
  • Teva Pharmaceutical Industries Ltd

第14章 付録

図表

List Of Tables

  • Table 1. Opioids Market Segmentation
  • Table 2. Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 4. Global Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • Table 5. Global Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
  • Table 6. Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 7. Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
  • Table 8. Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 9. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 10. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 11. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 12. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 13. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 14. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 15. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 16. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 17. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 18. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 19. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 20. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 21. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 22. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 23. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 24. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 25. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 26. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 27. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 28. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 29. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 30. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 31. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 32. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 33. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 34. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 35. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 36. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 37. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 38. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 39. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 40. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 41. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 42. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 43. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 44. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 45. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 46. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 47. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 48. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 49. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 50. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 51. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 52. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 53. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 54. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 55. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 56. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 57. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 58. France: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 59. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 60. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 61. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 62. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 63. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 64. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 65. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 66. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 67. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 68. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 69. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 70. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 71. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 72. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 73. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 74. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 75. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 76. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 77. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 78. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 79. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 80. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 81. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 82. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 83. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 84. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 85. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 86. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 87. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 88. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 89. China: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 90. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 91. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 92. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 93. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 94. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 95. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 96. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 97. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 98. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 99. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 100. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 101. India: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 102. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 103. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 104. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 105. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 106. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 107. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 108. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 109. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 110. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 111. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 112. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 113. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 114. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 115. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 116. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 117. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 118. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 119. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 120. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 121. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 122. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 123. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 124. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
  • Table 125. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 126. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 127. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 128. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 129. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
  • Table 130. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 131. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
  • Table 132. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 133. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 134. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 135. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
  • Table 136. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 137. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
  • Table 138. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 139. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 140. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 141. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
  • Table 142. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 143. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
  • Table 144. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 145. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 146. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 147. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
  • Table 148. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 149. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
  • Table 150. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 151. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 152. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 153. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
  • Table 154. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 155. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
  • Table 156. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 157. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 158. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 159. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 160. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
  • Table 161. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 162. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
  • Table 163. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 164. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 165. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 166. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long-Acting Opioid
  • Table 167. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 168. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
  • Table 169. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 170. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 171. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Immediate Release Short Acting Opioid
  • Table 172. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Extended Release Long Acting Opioid
  • Table 173. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 174. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Route Of Administration
  • Table 175. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 176. Recent Organic Growth Strategies in Opioids Market
  • Table 177. Recent Inorganic Growth Strategies in the Opioids Market
  • Table 178. Glossary of Terms, Opioids Market

List Of Figures

  • Figure 1. Opioids Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Opioids Market Revenue (US$ Million), 2022-2030
  • Figure 5. Opioids Market Breakdown by Geography, 2022 and 2030 (%)
  • Figure 6. Opioids Market Share (%) - by Product (2022 and 2030)
  • Figure 7. Immediate Release Short Acting Opioid: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Extended Release Long-Acting Opioid: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Opioids Market Share (%) - by Application (2022 and 2030)
  • Figure 10. Pain Management: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Anesthesia: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Diarrhoea Suppression: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Cough Suppression: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. De-Addiction: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Opioids Market Share (%) - by Route of Administration (2022 and 2030)
  • Figure 17. Oral: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Injectable: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Transdermal Patch: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
  • Figure 21. Hospital Pharmacies: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Retail Pharmacies: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Opioids Market Breakdown by Region, 2022 and 2030 (%)
  • Figure 24. North America: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 25. North America: Opioids Market Breakdown, by Route of Administration (2022 and 2030)
  • Figure 26. North America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 27. United States: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. Canada: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. Mexico: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 31. Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 32. United Kingdom: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 33. Germany: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 34. France: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. Italy: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. Spain: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. Rest of Europe: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 38. Asia Pacific: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 39. Asia Pacific: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 40. China: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 41. Japan: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 42. India: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 43. South Korea: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 44. Australia: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 45. Rest of APAC: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 46. Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 47. Saudi Arabia: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 48. South Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 49. United Arab Emirates: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 50. Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 51. South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 52. South and Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 53. Brazil: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 54. Argentina: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 55. Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 56. Growth Strategies in Opioids Market
目次
Product Code: TIPRE00004770

The Opioids market is expected to grow from US$ 12.93 billion in 2023 to US$ 15.03 billion by 2031; it is anticipated to record a CAGR of 1.9% from 2023 to 2031.

Opioids are a broad group of medicines majorly used for relieving pain. These medicines are highly effective but can also leads to an addiction. Opioid acts by working on brain receptors and thus provide the varieties of effect including the pain relief. Opioid includes heroin, morphine, codeine, fentanyl, methadone, tramadol, and other similar substances. The growing opioids market size is attributed to the surging chronic pain incidences across the world. In addition, the increasing geriatric population across the world are fueling opioid market growth. A government initiative focusing on the development of medication to prevent and treat opioid overdose and disorders is likely to bring new opioids market trends during the forecast period.

Strategic Initiatives by Market Players will Create an Opportunity for Opioid market growth.

Opioids market players invest in R&D activities to ensure the development of effective products. In May 2023, Indivior PLC received the US Food and Drug Administration (FDA) approval for OPVEE (nalmefene) nasal spray for emergency use to treat suspected or known opioid overdose induced by synthetic or natural opioids in adults and pediatric patients aged 12 years and more, which is characterized by CNS and/or respiratory depression. Further, in December 2021, Sandoz announced the launch of its generic Narcan (naloxone hydrochloride) Nasal Spray 4mg in the US; the product is used to reverse opioid overdose. Individuals in the US can immediately obtain Narcan via retail pharmacies and institutions, including hospitals. Lastly, in August 2023, Emergent BioSolutions launched the over-the-counter NARCAN Nasal Spray, making it possible for everybody to help save a life from an opioid overdose emergency. Therefore, strategic initiatives are likely to offer growth opportunities to the opioids market in the coming years.

Based on geography, the Opioid market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, Southeast Asia, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America). North America held the largest share of the global Opioid market in 2023 owing to the lifestyle factor. However, Asia Pacific is predicted to register the highest CAGR during 2023-2031. The US held the largest share of the Opioid market in North America in 2022. US market players are adopting organic and inorganic strategies for Opioid market development. For instance, in 2024, Hikma Pharmaceuticals PLC launched Fentanyl Citrate Injection, USP, in 25mcg/0.5mL and 50mcg/mL doses. Hikma introduced the first FDA approved 25mcg/0.5mL presentation to the US market. The company is expected to expand its portfolio with the launch, broadening the choice of medicines available to hospitals. Furthermore, in 2023, Rusan Pharma launched its state-of-the-art API facility in Madhya Pradesh, India. The facility is designed to meet stringent international regulatory guidelines, ensuring the highest level of compliance. With the production capability of 400 metric tons of APIs annually. This facility expansion will ensure the security of supply of critical APIs to meet the growing demand for addiction treatment and pain management products in India and globally. Moreover in 2023, Neuraxpharm announced the closing of the acquisition of two established product portfolios for CNS disorders, pain and vascular diseases from Sanofi. The well-established products that Neuraxpharm acquired includes 15 products addressing CNS disorders and two products in pain and vascular diseases, and in 2022, Collegium Pharmaceutical, Inc. announced that it completed the acquisition of BioDelivery Sciences International Inc. BDSI has a portfolio of pain and neurology products that address serious and debilitating conditions. BDSI's commercial growth driver, BELBUCA, is a meaningfully differentiated schedule III opioid product and is highly complementary to Collegium's portfolio of pain products. Thus, the factors mentioned above support the market growth.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Opioids Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Opioids Market - Key Market Dynamics

  • 5.1 Opioids Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Surging Chronic Pain Incidence
    • 5.2.2 Increasing Geriatric Population
  • 5.3 Market Restraints
    • 5.3.1 Increasing Drug Abuse
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Market Players
  • 5.5 Future Trends
    • 5.5.1 Government Initiatives Focusing on Development of Medication to Prevent and Treat Opioid Overdose and Disorder
  • 5.6 Impact of Drivers and Restraints:

6. Opioids Market - Global Market Analysis

  • 6.1 Opioids Market Revenue (US$ Million), 2022-2030
  • 6.2 Opioids Market Forecast Analysis

7. Opioids Market Analysis - by Product

  • 7.1 Immediate Release Short Acting Opioid
    • 7.1.1 Overview
    • 7.1.2 Immediate Release Short Acting Opioid: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.1 Global Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • 7.2 Extended Release Long-Acting Opioid
    • 7.2.1 Overview
    • 7.2.2 Extended Release Long-Acting Opioid: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.2.2.1 Global Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

8. Opioids Market Analysis - by Application

  • 8.1 Pain Management
    • 8.1.1 Overview
    • 8.1.2 Pain Management: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Anesthesia
    • 8.2.1 Overview
    • 8.2.2 Anesthesia: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Diarrhoea Suppression
    • 8.3.1 Overview
    • 8.3.2 Diarrhoea Suppression: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Cough Suppression
    • 8.4.1 Overview
    • 8.4.2 Cough Suppression: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 De-Addiction
    • 8.5.1 Overview
    • 8.5.2 De-Addiction: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Opioids Market - Revenue and Forecast to 2030 (US$ Million)

9. Opioids Market Analysis - by Route of Administration

  • 9.1 Oral
    • 9.1.1 Overview
    • 9.1.2 Oral: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Injectable
    • 9.2.1 Overview
    • 9.2.2 Injectable: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Transdermal Patch
    • 9.3.1 Overview
    • 9.3.2 Transdermal Patch: Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10. Opioids Market Analysis - by Distribution Channel

  • 10.1 Hospital Pharmacies
    • 10.1.1 Overview
    • 10.1.2 Hospital Pharmacies: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Retail Pharmacies
    • 10.2.1 Overview
    • 10.2.2 Retail Pharmacies: Opioids Market - Revenue and Forecast to 2030 (US$ Million)

11. Opioids Market - Geographical Analysis

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 North America Opioids Market Overview
    • 11.2.2 North America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.2.2.1 North America: Opioids Market - Revenue and Forecast Analysis - by Product
    • 11.2.3 North America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
      • 11.2.3.1 North America: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
      • 11.2.3.2 North America: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long-Acting Opioid
      • 11.2.3.3 North America: Opioids Market - Revenue and Forecast Analysis - by Application
    • 11.2.4 North America: Opioids Market Breakdown, by Route of Administration
      • 11.2.4.1 North America: Opioids Market - Revenue and Forecast Analysis - by Route of Administration
      • 11.2.4.2 North America: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.2.5 North America: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.2.5.1 North America: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.2.5.2 United States: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.5.2.1 United States: Opioids Market Breakdown, by Product
        • 11.2.5.2.2 United States: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.2.5.2.3 United States: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.2.5.2.4 United States: Opioids Market Breakdown, by Application
        • 11.2.5.2.5 United States: Opioids Market Breakdown, by Route of Administration
        • 11.2.5.2.6 United States: Opioids Market Breakdown, by Distribution Channel
      • 11.2.5.3 Canada: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.5.3.1 Canada: Opioids Market Breakdown, by Product
        • 11.2.5.3.2 Canada: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.2.5.3.3 Canada: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.2.5.3.4 Canada: Opioids Market Breakdown, by Application
        • 11.2.5.3.5 Canada: Opioids Market Breakdown, by Route of Administration
        • 11.2.5.3.6 Canada: Opioids Market Breakdown, by Distribution Channel
      • 11.2.5.4 Mexico: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.5.4.1 Mexico: Opioids Market Breakdown, by Product
        • 11.2.5.4.2 Mexico: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.2.5.4.3 Mexico: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.2.5.4.4 Mexico: Opioids Market Breakdown, by Application
        • 11.2.5.4.5 Mexico: Opioids Market Breakdown, by Route of Administration
        • 11.2.5.4.6 Mexico: Opioids Market Breakdown, by Distribution Channel
  • 11.3 Europe
    • 11.3.1 Europe Opioids Market Overview
    • 11.3.2 Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.3.3 Europe: Opioids Market Breakdown, by Product
      • 11.3.3.1 Europe: Opioids Market - Revenue and Forecast Analysis - by Product
      • 11.3.3.2 Europe: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
      • 11.3.3.3 Europe: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long-Acting Opioid
      • 11.3.3.4 Europe: Opioids Market - Revenue and Forecast Analysis - by Application
      • 11.3.3.5 Europe: Opioids Market - Revenue and Forecast Analysis - by Route of Administration
      • 11.3.3.6 Europe: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.3.4 Europe: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.3.4.1 Europe: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.3.4.2 United Kingdom: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.4.2.1 United Kingdom: Opioids Market Breakdown, by Product
        • 11.3.4.2.2 United Kingdom: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.3.4.2.3 United Kingdom: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.3.4.2.4 United Kingdom: Opioids Market Breakdown, by Application
        • 11.3.4.2.5 United Kingdom: Opioids Market Breakdown, by Route of Administration
        • 11.3.4.2.6 United Kingdom: Opioids Market Breakdown, by Distribution Channel
      • 11.3.4.3 Germany: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.4.3.1 Germany: Opioids Market Breakdown, by Product
        • 11.3.4.3.2 Germany: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.3.4.3.3 Germany: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.3.4.3.4 Germany: Opioids Market Breakdown, by Application
        • 11.3.4.3.5 Germany: Opioids Market Breakdown, by Route of Administration
        • 11.3.4.3.6 Germany: Opioids Market Breakdown, by Distribution Channel
      • 11.3.4.4 France: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.4.4.1 France: Opioids Market Breakdown, by Product
        • 11.3.4.4.2 France: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.3.4.4.3 France: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.3.4.4.4 France: Opioids Market Breakdown, by Application
        • 11.3.4.4.5 France: Opioids Market Breakdown, by Route of Administration
        • 11.3.4.4.6 France: Opioids Market Breakdown, by Distribution Channel
      • 11.3.4.5 Italy: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.4.5.1 Italy: Opioids Market Breakdown, by Product
        • 11.3.4.5.2 Italy: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.3.4.5.3 Italy: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.3.4.5.4 Italy: Opioids Market Breakdown, by Application
        • 11.3.4.5.5 Italy: Opioids Market Breakdown, by Route of Administration
        • 11.3.4.5.6 Italy: Opioids Market Breakdown, by Distribution Channel
      • 11.3.4.6 Spain: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.4.6.1 Spain: Opioids Market Breakdown, by Product
        • 11.3.4.6.2 Spain: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.3.4.6.3 Spain: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.3.4.6.4 Spain: Opioids Market Breakdown, by Application
        • 11.3.4.6.5 Spain: Opioids Market Breakdown, by Route of Administration
        • 11.3.4.6.6 Spain: Opioids Market Breakdown, by Distribution Channel
      • 11.3.4.7 Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.4.7.1 Rest of Europe: Opioids Market Breakdown, by Product
        • 11.3.4.7.2 Rest of Europe: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.3.4.7.3 Rest of Europe: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.3.4.7.4 Rest of Europe: Opioids Market Breakdown, by Application
        • 11.3.4.7.5 Rest of Europe: Opioids Market Breakdown, by Route of Administration
        • 11.3.4.7.6 Rest of Europe: Opioids Market Breakdown, by Distribution Channel
  • 11.4 Asia Pacific
    • 11.4.1 Asia Pacific Opioids Market Overview
    • 11.4.2 Asia Pacific: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.4.2.1 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Product
      • 11.4.2.2 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
      • 11.4.2.3 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long-Acting Opioid
      • 11.4.2.4 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Application
      • 11.4.2.5 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Route of Administration
      • 11.4.2.6 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.4.3 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.1 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.2 China: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.2.1 China: Opioids Market Breakdown, by Product
        • 11.4.3.2.2 China: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.4.3.2.3 China: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.4.3.2.4 China: Opioids Market Breakdown, by Application
        • 11.4.3.2.5 China: Opioids Market Breakdown, by Route of Administration
        • 11.4.3.2.6 China: Opioids Market Breakdown, by Distribution Channel
      • 11.4.3.3 Japan: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.3.1 Japan: Opioids Market Breakdown, by Product
        • 11.4.3.3.2 Japan: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.4.3.3.3 Japan: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.4.3.3.4 Japan: Opioids Market Breakdown, by Application
        • 11.4.3.3.5 Japan: Opioids Market Breakdown, by Route of Administration
        • 11.4.3.3.6 Japan: Opioids Market Breakdown, by Distribution Channel
      • 11.4.3.4 India: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.4.1 India: Opioids Market Breakdown, by Product
        • 11.4.3.4.2 India: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.4.3.4.3 India: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.4.3.4.4 India: Opioids Market Breakdown, by Application
        • 11.4.3.4.5 India: Opioids Market Breakdown, by Route of Administration
        • 11.4.3.4.6 India: Opioids Market Breakdown, by Distribution Channel
      • 11.4.3.5 South Korea: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.5.1 South Korea: Opioids Market Breakdown, by Product
        • 11.4.3.5.2 South Korea: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.4.3.5.3 South Korea: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.4.3.5.4 South Korea: Opioids Market Breakdown, by Application
        • 11.4.3.5.5 South Korea: Opioids Market Breakdown, by Route of Administration
        • 11.4.3.5.6 South Korea: Opioids Market Breakdown, by Distribution Channel
      • 11.4.3.6 Australia: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.6.1 Australia: Opioids Market Breakdown, by Product
        • 11.4.3.6.2 Australia: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.4.3.6.3 Australia: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.4.3.6.4 Australia: Opioids Market Breakdown, by Application
        • 11.4.3.6.5 Australia: Opioids Market Breakdown, by Route of Administration
        • 11.4.3.6.6 Australia: Opioids Market Breakdown, by Distribution Channel
      • 11.4.3.7 Rest of APAC: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.7.1 Rest of APAC: Opioids Market Breakdown, by Product
        • 11.4.3.7.2 Rest of APAC: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.4.3.7.3 Rest of APAC: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.4.3.7.4 Rest of APAC: Opioids Market Breakdown, by Application
        • 11.4.3.7.5 Rest of APAC: Opioids Market Breakdown, by Route of Administration
        • 11.4.3.7.6 Rest of APAC: Opioids Market Breakdown, by Distribution Channel
  • 11.5 Middle East and Africa
    • 11.5.1 Middle East and Africa Opioids Market Overview
    • 11.5.2 Middle East and Africa: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.5.2.1 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Product
      • 11.5.2.2 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
      • 11.5.2.3 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long-Acting Opioid
      • 11.5.2.4 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Application
      • 11.5.2.5 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Route of Administration
      • 11.5.2.6 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
      • 11.5.2.7 Middle East and Africa: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.5.2.8 Saudi Arabia: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.2.8.1 Saudi Arabia: Opioids Market Breakdown, by Product
        • 11.5.2.8.2 Saudi Arabia: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.5.2.8.3 Saudi Arabia: Opioids Market Breakdown, by Extended Release Long Acting Opioid
        • 11.5.2.8.4 Saudi Arabia: Opioids Market Breakdown, by Application
        • 11.5.2.8.5 Saudi Arabia: Opioids Market Breakdown, by Route Of Administration
        • 11.5.2.8.6 Saudi Arabia: Opioids Market Breakdown, by Distribution Channel
      • 11.5.2.9 South Africa: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.2.9.1 South Africa: Opioids Market Breakdown, by Product
        • 11.5.2.9.2 South Africa: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.5.2.9.3 South Africa: Opioids Market Breakdown, by Extended Release Long Acting Opioid
        • 11.5.2.9.4 South Africa: Opioids Market Breakdown, by Application
        • 11.5.2.9.5 South Africa: Opioids Market Breakdown, by Route Of Administration
        • 11.5.2.9.6 South Africa: Opioids Market Breakdown, by Distribution Channel
      • 11.5.2.10 United Arab Emirates: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.2.10.1 United Arab Emirates: Opioids Market Breakdown, by Product
        • 11.5.2.10.2 United Arab Emirates: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.5.2.10.3 United Arab Emirates: Opioids Market Breakdown, by Extended Release Long Acting Opioid
        • 11.5.2.10.4 United Arab Emirates: Opioids Market Breakdown, by Application
        • 11.5.2.10.5 United Arab Emirates: Opioids Market Breakdown, by Route Of Administration
        • 11.5.2.10.6 United Arab Emirates: Opioids Market Breakdown, by Distribution Channel
      • 11.5.2.11 Rest of Middle East and Africa: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.2.11.1 Rest of Middle East and Africa: Opioids Market Breakdown, by Product
        • 11.5.2.11.2 Rest of Middle East and Africa: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.5.2.11.3 Rest of Middle East and Africa: Opioids Market Breakdown, by Extended Release Long Acting Opioid
        • 11.5.2.11.4 Rest of Middle East and Africa: Opioids Market Breakdown, by Application
        • 11.5.2.11.5 Rest of Middle East and Africa: Opioids Market Breakdown, by Route Of Administration
        • 11.5.2.11.6 Rest of Middle East and Africa: Opioids Market Breakdown, by Distribution Channel
  • 11.6 South and Central America
    • 11.6.1 South and Central America Opioids Market Overview
    • 11.6.2 South and Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.6.2.1 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Product
      • 11.6.2.2 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Immediate Release Short Acting Opioid
      • 11.6.2.3 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Extended Release Long Acting Opioid
      • 11.6.2.4 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Application
      • 11.6.2.5 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Route Of Administration
      • 11.6.2.6 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.6.3 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.6.3.1 South and Central America: Opioids Market - Revenue and Forecast Analysis - by Country
      • 11.6.3.2 Brazil: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.6.3.2.1 Brazil: Opioids Market Breakdown, by Product
        • 11.6.3.2.2 Brazil: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.6.3.2.3 Brazil: Opioids Market Breakdown, by Extended Release Long Acting Opioid
        • 11.6.3.2.4 Brazil: Opioids Market Breakdown, by Application
        • 11.6.3.2.5 Brazil: Opioids Market Breakdown, by Route Of Administration
        • 11.6.3.2.6 Brazil: Opioids Market Breakdown, by Distribution Channel
      • 11.6.3.3 Argentina: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.6.3.3.1 Argentina: Opioids Market Breakdown, by Product
        • 11.6.3.3.2 Argentina: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.6.3.3.3 Argentina: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 11.6.3.3.4 Argentina: Opioids Market Breakdown, by Application
        • 11.6.3.3.5 Argentina: Opioids Market Breakdown, by Route Of Administration
        • 11.6.3.3.6 Argentina: Opioids Market Breakdown, by Distribution Channel
      • 11.6.3.4 Rest of South and Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.6.3.4.1 Rest of South and Central America: Opioids Market Breakdown, by Product
        • 11.6.3.4.2 Rest of South and Central America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 11.6.3.4.3 Rest of South and Central America: Opioids Market Breakdown, by Extended Release Long Acting Opioid
        • 11.6.3.4.4 Rest of South and Central America: Opioids Market Breakdown, by Application
        • 11.6.3.4.5 Rest of South and Central America: Opioids Market Breakdown, by Route Of Administration
        • 11.6.3.4.6 Rest of South and Central America: Opioids Market Breakdown, by Distribution Channel

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Opioids Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Purdue Pharma LP
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Endo International plc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Mallinckrodt Plc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Collegium Pharmaceutical Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Neuraxpharm Pharmaceuticals SL
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Hikma Pharmaceuticals Plc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Mayne Pharma Group Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Rusan Pharma Ltd
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Trevena Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Teva Pharmaceutical Industries Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms